Search research articles
Contact Us
Filters
Showing results (91-100 of 103) with videos related to
Page
of 11
Sort By:
Pharmaceutical Research
|
November 8, 2019
Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab
Shea Jassem, Wei Wang, Heather Sweet, et al.
JAMA Surgery
|
April 10, 2024
Automated CT Analysis of Body Composition as a Frailty Biomarker in Abdominal Surgery
Ijeamaka Anyene Fumagalli, Sidney T Le, Peter D Peng, et al.
Heart, Lung & Circulation
|
December 30, 2023
Trends in Isolated Mitral Valve Repair or Replacement Surgery in Australia: A Statewide Cohort Linkage Study
Yeu-Yao Cheng, Matthew Wei Shun Shu, Imants Rubenis, et al.
The American Journal of Cardiology
|
July 1, 2011
Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999-2007
Isuru Ranasinghe, Bernadette Alprandi-Costa, Vincent Chow, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
December 23, 2024
CT-Based Body Composition and Frailty as Predictors of Survival Among Older Adults With Gastrointestinal Malignancies
Smith Giri, Christian Harmon, Daniel Hess, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
June 14, 2025
Automated three-dimensional body composition analysis identifies visceral adipose tissue radiodensity as a predictor of mortality and recurrence in colorectal cancer
Dinh Van Chi Mai, Ioanna Drami, Edward T Pring, et al.
American Journal of Hematology
|
August 22, 2024
Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria
Austin Kulasekararaj, Francesco Lanza, Alexandros Arvanitakis, et al.
Thrombosis and Haemostasis
|
February 5, 2016
High mortality in patients presenting with acute pulmonary embolism and elevated INR not on anticoagulant therapy
Christopher C Y Wong, Austin C C Ng, Jerrett K Lau, et al.
Journal of Pharmaceutical Sciences
|
February 3, 2015
Utilizing physiologically based pharmacokinetic modeling to inform formulation and clinical development for a compound with pH-dependent solubility
John Chung, Fernando Alvarez-Nunez, Vincent Chow, et al.
Investigational New Drugs
|
July 8, 2018
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors
Michael Carducci, Montaser Shaheen, Ben Markman, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 103) with videos related to
Sort By:
Page
of 11
Pharmaceutical Research
|
November 8, 2019
Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab
Shea Jassem, Wei Wang, Heather Sweet, et al.
JAMA Surgery
|
April 10, 2024
Automated CT Analysis of Body Composition as a Frailty Biomarker in Abdominal Surgery
Ijeamaka Anyene Fumagalli, Sidney T Le, Peter D Peng, et al.
Heart, Lung & Circulation
|
December 30, 2023
Trends in Isolated Mitral Valve Repair or Replacement Surgery in Australia: A Statewide Cohort Linkage Study
Yeu-Yao Cheng, Matthew Wei Shun Shu, Imants Rubenis, et al.
The American Journal of Cardiology
|
July 1, 2011
Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999-2007
Isuru Ranasinghe, Bernadette Alprandi-Costa, Vincent Chow, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
December 23, 2024
CT-Based Body Composition and Frailty as Predictors of Survival Among Older Adults With Gastrointestinal Malignancies
Smith Giri, Christian Harmon, Daniel Hess, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
June 14, 2025
Automated three-dimensional body composition analysis identifies visceral adipose tissue radiodensity as a predictor of mortality and recurrence in colorectal cancer
Dinh Van Chi Mai, Ioanna Drami, Edward T Pring, et al.
American Journal of Hematology
|
August 22, 2024
Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria
Austin Kulasekararaj, Francesco Lanza, Alexandros Arvanitakis, et al.
Thrombosis and Haemostasis
|
February 5, 2016
High mortality in patients presenting with acute pulmonary embolism and elevated INR not on anticoagulant therapy
Christopher C Y Wong, Austin C C Ng, Jerrett K Lau, et al.
Journal of Pharmaceutical Sciences
|
February 3, 2015
Utilizing physiologically based pharmacokinetic modeling to inform formulation and clinical development for a compound with pH-dependent solubility
John Chung, Fernando Alvarez-Nunez, Vincent Chow, et al.
Investigational New Drugs
|
July 8, 2018
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors
Michael Carducci, Montaser Shaheen, Ben Markman, et al.
Page
of 11